{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:13:51Z","timestamp":1788092031171,"version":"build-2803163510"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Swedish Heart and Lung foundation, CIMED, Vinnova","award":["2022-03484"],"award-info":[{"award-number":["2022-03484"]}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2022-01466"],"award-info":[{"award-number":["2022-01466"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Region Stockholm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Population-based screening for atrial fibrillation (AF) should be considered in elderly individuals to enable AF detection. However, participation in systematic screening programmes is often suboptimal. STROKESTOP III evaluated whether opportunistic screening could improve participation compared with systematic screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>STROKESTOP III is a cluster-randomized trial including individuals aged 75\u201376 years from 16 primary care centres in Region V\u00e4rmland, Sweden. Centres were randomized to systematic screening, using mailed invitations, or opportunistic screening, using invitations during visits.<\/jats:p>\n                    <jats:p>In the systematic arm, 1312 individuals were eligible and invited, of whom 607 participated (46.3%). In the opportunistic arm, 1390 individuals attended participating primary care centres and were potentially eligible for invitation. However, 641 individuals (46.1%) were not assessed for eligibility. Among the 749 assessed individuals, 609 were eligible and 374 participated.<\/jats:p>\n                    <jats:p>Participation among invited eligible individuals was significantly higher with opportunistic than systematic screening (374\/609, 61.4% vs. 607\/1,312, 46.3%; P &amp;lt; 0.005). However, overall reach was lower in the opportunistic arm because of incomplete assessment for invitation (374\/1,479, 25.3% vs. 607\/1,437, 42.2%; P &amp;lt; 0.005). Participants in the opportunistic arm had a higher cardiovascular risk burden, including more hypertension, diabetes, and a higher CHA2DS2-VASc-score (3.99 vs. 3.60; P &amp;lt; 0.005). Exclusion rates were higher (18.7% vs. 8.7%; P &amp;lt; 0.005), mainly due to previously diagnosed AF and cognitive impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Opportunistic screening increased participation among invited individuals and identified a higher-risk population, but its overall population reach was limited by incomplete eligibility assessment. Combining opportunistic and systematic strategies may optimize reach and participation in AF screening programmes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euag214","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:14:01Z","timestamp":1786706041000},"source":"Crossref","is-referenced-by-count":0,"title":["Population reach and participation rate in opportunistic vs. systematic atrial fibrillation screening: STROKESTOP III"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1615-5173","authenticated-orcid":false,"given":"Mashroor","family":"Khan","sequence":"first","affiliation":[{"name":"Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge , Stockholm SE 141 86 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6360-1167","authenticated-orcid":false,"given":"Sofia","family":"Skr\u00f6der","sequence":"additional","affiliation":[{"name":"Centre for Clinical Research and Education , Region V\u00e4rmland, Karlstad ,","place":["Sweden"]},{"name":"Faculty of Medicine and Health, School of Medical Sciences, \u00d6rebro University , \u00d6rebro ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ingre","sequence":"additional","affiliation":[{"name":"Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge , Stockholm SE 141 86 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Carlstedt","sequence":"additional","affiliation":[{"name":"Centre for Clinical Research and Education , Region V\u00e4rmland, Karlstad ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Eriksson","sequence":"additional","affiliation":[{"name":"Department of Clinical Physiology , Region V\u00e4rmland, Karlstad ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Star Tenn","sequence":"additional","affiliation":[{"name":"Department of Clinical Physiology , Region V\u00e4rmland, Karlstad ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3337-9259","authenticated-orcid":false,"given":"M\u00e5rten","family":"Rosenqvist","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet , Danderyd ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6413-0870","authenticated-orcid":false,"given":"Emma","family":"Svennberg","sequence":"additional","affiliation":[{"name":"Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge , Stockholm SE 141 86 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,30]]},"reference":[{"key":"2026083007161976800_euag214-B1","first-page":"467","article-title":"Atrial fibrillation associated with heart failure, stroke and mortality","volume":"5","author":"Bordignon","year":"2012","journal-title":"J Atr Fibrillation"},{"key":"2026083007161976800_euag214-B2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCULATIONAHA.121.055018","article-title":"Atrial fibrillation and dementia: a report from the AF-SCREEN international collaboration","volume":"145","author":"Rivard","year":"2022","journal-title":"Circulation"},{"key":"2026083007161976800_euag214-B3","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11092510","article-title":"Atrial fibrillation and heart failure","volume":"11","author":"Bergau","year":"2022","journal-title":"J Clin Med"},{"key":"2026083007161976800_euag214-B4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/joim.13217","article-title":"Large-scale screening studies for atrial fibrillation - is it worth the effort?","volume":"289","author":"Engdahl","year":"2021","journal-title":"J Intern Med"},{"key":"2026083007161976800_euag214-B5","doi-asserted-by":"crossref","first-page":"euae195","DOI":"10.1093\/europace\/euae195","article-title":"Global burden of atrial fibrillation\/atrial flutter and its attributable risk factors from 1990 to 2021","volume":"26","author":"Cheng","year":"2024","journal-title":"Europace"},{"key":"2026083007161976800_euag214-B6","doi-asserted-by":"crossref","first-page":"euaf027","DOI":"10.1093\/europace\/euaf027","article-title":"Global, regional, and national burden of atrial fibrillation and atrial flutter from 1990 to 2021: sex differences and global burden projections to 2046-a systematic analysis of the global burden of disease study 2021","volume":"27","author":"Tan","year":"2025","journal-title":"Europace"},{"key":"2026083007161976800_euag214-B7","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.114.014343","article-title":"Mass screening for untreated atrial fibrillation: the STROKESTOP study","volume":"131","author":"Svennberg","year":"2015","journal-title":"Circulation"},{"key":"2026083007161976800_euag214-B8","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026083007161976800_euag214-B9","doi-asserted-by":"crossref","first-page":"euae298","DOI":"10.1093\/europace\/euae298","article-title":"Spotlight on the 2024 ESC\/EACTS management of atrial fibrillation guidelines: 10 novel key aspects","volume":"26","author":"Rienstra","year":"2024","journal-title":"Europace"},{"key":"2026083007161976800_euag214-B10","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(21)01637-8","article-title":"Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial","volume":"398","author":"Svennberg","year":"2021","journal-title":"Lancet"},{"key":"2026083007161976800_euag214-B11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/eurheartj\/ehac547","article-title":"Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study","volume":"44","author":"Lyth","year":"2023","journal-title":"Eur Heart J"},{"key":"2026083007161976800_euag214-B12","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/CIRCULATIONAHA.124.071176","article-title":"Randomized invitation to systematic NT-proBNP and ECG screening in 75-year-olds to detect atrial fibrillation: STROKESTOP II","volume":"150","author":"Kemp Gudmundsdottir","year":"2024","journal-title":"Circulation"},{"key":"2026083007161976800_euag214-B13","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2025-326121","article-title":"Present state and future of screening for atrial fibrillation: a state-of-the-art review","author":"Svennberg","year":"2026","journal-title":"Heart"},{"key":"2026083007161976800_euag214-B14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198069","article-title":"Feasibility and outcomes of atrial fibrillation screening using intermittent electrocardiography in a primary healthcare setting: a cross-sectional study","volume":"13","author":"Ghazal","year":"2018","journal-title":"PLoS One"},{"key":"2026083007161976800_euag214-B15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/CIRCULATIONAHA.121.057014","article-title":"Screening for atrial fibrillation in older adults at primary care visits: VITAL-AF randomized controlled trial","volume":"145","author":"Lubitz","year":"2022","journal-title":"Circulation"},{"key":"2026083007161976800_euag214-B16","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta9400","article-title":"A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study","volume":"9","author":"Hobbs","year":"2005","journal-title":"Health Technol Assess"},{"key":"2026083007161976800_euag214-B17","doi-asserted-by":"crossref","first-page":"euae234","DOI":"10.1093\/europace\/euae234","article-title":"Increasing the reach: optimizing screening for atrial fibrillation-the STROKESTOP III study","volume":"26","author":"Khan","year":"2024","journal-title":"Europace"},{"key":"2026083007161976800_euag214-B18","first-page":"1449","article-title":"Safe automatic one-lead electrocardiogram analysis in screening for atrial fibrillation","volume":"19","author":"Svennberg","year":"2017","journal-title":"Europace"},{"key":"2026083007161976800_euag214-B19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035564","article-title":"Empirical power and sample size calculations for cluster-randomized and cluster-randomized crossover studies","volume":"7","author":"Reich","year":"2012","journal-title":"PLoS One"},{"key":"2026083007161976800_euag214-B20","doi-asserted-by":"crossref","first-page":"euaf032","DOI":"10.1093\/europace\/euaf032","article-title":"PULSE survey: population survey on knowledge, gaps and perception of heart rhythm disorders-an initiative of the scientific initiatives committee of the European heart rhythm association","volume":"27","author":"Gunawardene","year":"2025","journal-title":"Europace"},{"key":"2026083007161976800_euag214-B21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065066","article-title":"Cluster randomised controlled trial of screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the pilot study for the SAFER trial","volume":"12","author":"Williams","year":"2022","journal-title":"BMJ Open"},{"key":"2026083007161976800_euag214-B22","doi-asserted-by":"crossref","first-page":"euae056","DOI":"10.1093\/europace\/euae056","article-title":"The feasibility of population screening for paroxysmal atrial fibrillation using hand-held electrocardiogram devices","volume":"26","author":"Mant","year":"2024","journal-title":"Europace"},{"key":"2026083007161976800_euag214-B23","doi-asserted-by":"crossref","first-page":"euae012","DOI":"10.1093\/europace\/euae012","article-title":"Current management of atrial fibrillation in routine practice according to the last ESC guidelines: an EHRA physician survey-how are we dealing with controversial approaches?","volume":"26","author":"Guerra","year":"2024","journal-title":"Europace"},{"key":"2026083007161976800_euag214-B24","doi-asserted-by":"crossref","first-page":"euaf190","DOI":"10.1093\/europace\/euaf190","article-title":"Systematic, randomized atrial fibrillation screening using detailed phenotyping with a risk prediction model combined with patch electrocardiogram in a Swedish population aged 65 years or older: the CONSIDERING-AF trial","volume":"27","author":"Rakai","year":"2025","journal-title":"Europace"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/8\/euag214\/70827801\/euag214.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/8\/euag214\/70827801\/euag214.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T11:16:45Z","timestamp":1788088605000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euag214\/8772307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,4]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euag214","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8]]},"article-number":"euag214"}}